ALTUVOCT
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 May 2024)
What this means for you
This application is over — abandoned 13 May 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97403774
- Mark type
- Stylized text
- Filed
- 10 May 2022
- Published for opposition
- 16 Aug 2022
- Abandoned
- 13 May 2024
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of diseases in the immunology field
Owner
- Bioverativ Therapeutics Inc., Waltham, MA, US
- Bioverativ Therapeutics Inc., Waltham, MA, US
Prosecution history
- 13 May 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 May 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2023 — SOU EXTENSION 2 GRANTED
- 30 Aug 2023 — SOU EXTENSION 2 FILED
- 30 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Apr 2023 — SOU EXTENSION 1 GRANTED
- 05 Apr 2023 — SOU EXTENSION 1 FILED
- 05 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Aug 2022 — PUBLISHED FOR OPPOSITION
- 27 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jul 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER